Risk of Hyponatremia with Diuretics: Chlorthalidone versus Hydrochlorothiazide

• Published in: The American journal of medicine Vol. 127; no. 8; pp. 763 - 771
• Main Authors: van Blijderveen, Jan C., Straus, Sabine M., Rodenburg, Eline M., Zietse, Robert, Stricker, Bruno H., Sturkenboom, Miriam C., Verhamme, Katia M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2014; Elsevier Sequoia S.A
• Subjects: Adolescent; Adult; adverse drug reaction; Aged; Case-Control Studies; chlorthalidone; Chlorthalidone - adverse effects; Clinical outcomes; Diuretics; Diuretics - adverse effects; Drug dosages; Female; Humans; hydrochlorothiazide; Hydrochlorothiazide - adverse effects; hyponatremia; Hyponatremia - chemically induced; Internal Medicine; Male; matched case-control study; Middle Aged; Odds Ratio; Risk Factors; Side effects; Sodium; Young Adult; chlorthalidone; matched case-control study; adverse drug reaction; hyponatremia; hydrochlorothiazide
• ISSN: 0002-9343; 1555-7162; 1555-7162
• DOI: 10.1016/j.amjmed.2014.04.014

Chlorthalidone and hydrochlorothiazide are often considered as interchangeable. However, greater (nighttime) blood pressure reduction, and alleged pleiotropic effects have renewed the interest in chlorthalidone. A recent study showed an increased risk of adverse events with chlorthalidone, including hyponatremia. To investigate differences in risk of hyponatremia between chlorthalidone and hydrochlorothiazide, adjusted for daily dose, we conducted a population-based case-control study within the Dutch IPCI (Integrated Primary Care Information) database. The study population included all subjects ≥18 years without diabetes mellitus, heart failure, liver failure, and malignancy, who were registered in the IPCI database from 1996 to 2011. Cases were subjects with a serum sodium <130 millimoles per liter or hospitalization due to hyponatremia. Controls were matched on practice, age within 5 years, sex, and date of onset. A total of 1033 cases of hyponatremia were identified. Hyponatremia was more common with chlorthalidone than with hydrochlorothiazide at equal dose per day: adjusted odds ratio was 2.09 (95% confidence interval [CI], 1.13-3.88) for 12.5 milligrams per day and 1.72 (95% CI, 1.15-2.57) for 25 milligrams per day. Risks were not significantly increased with chlorthalidone compared with twice the dose per day of hydrochlorothiazide. This is the first study that shows an increased risk of hyponatremia with chlorthalidone relative to hydrochlorothiazide at equal milligram-to-milligram dose per day. The need for a lower dose of chlorthalidone than hydrochlorothiazide to achieve similar blood pressure reduction likely compensates for the increased risk of hyponatremia at equal dose.